Shopping Cart
Remove All
Your shopping cart is currently empty
BPR1M97 is a mu opioid receptor (MOP) and neuropeptide-orphin FQ (NOP) receptor agonist with blood-brain barrier permeability and potency, with Kis values of 1.8 nM for MOP and 4.2 nM for NOP.BPR1M97 exhibits anti-injurious effects and antinociceptive effects.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $41 | In Stock | In Stock | |
| 5 mg | $100 | In Stock | In Stock | |
| 10 mg | $159 | In Stock | In Stock | |
| 25 mg | $292 | In Stock | In Stock | |
| 50 mg | $457 | In Stock | In Stock | |
| 100 mg | $643 | In Stock | In Stock | |
| 1 mL x 10 mM (in DMSO) | $95 | In Stock | In Stock |
| Description | BPR1M97 is a mu opioid receptor (MOP) and neuropeptide-orphin FQ (NOP) receptor agonist with blood-brain barrier permeability and potency, with Kis values of 1.8 nM for MOP and 4.2 nM for NOP.BPR1M97 exhibits anti-injurious effects and antinociceptive effects. |
| Targets&IC50 | NOP:4.2 nM (ki), MOP:1.8 nM (ki) |
| In vivo | In a murine model of cancer pain, BPR1M97 (1.8 mg/kg; s.c.; once) demonstrates antinociception.[1] |
| Molecular Weight | 349.25 |
| Formula | C18H18Cl2N2O |
| Cas No. | 2059904-66-2 |
| Smiles | CN1CCc2ccccc2C1CNC(=O)c1ccc(Cl)c(Cl)c1 |
| Relative Density. | 1.260 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 225.0 mg/mL (644.2 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (14.32 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.